home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  Carlo Gambacorti: DIAG: 3 messages (1 PT REQ)  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL>
Subject: DIAG: 3 messages (1 PT REQ)
From: Carlo Gambacorti <GAMBACORTI@icil64.cilea.it>
Date: Fri, 12 Jan 1996 09:39:27 MET-DST

**************************************************************
           HUM-MOLGEN  DIAGnostics/Clinical Research
**************************************************************


This DIAG message contains 3 submessage(s):

1)   Bazex-Dupre-Christol Syndrome

2)   familial hypercholesterolemia

3)   PT REQ./Werdnig-Hoffmann disease


  Carlo Gambacorti MD, Editor,
  Human Molecular Genetics network
  Diagnostics/Clinical Research Section


**************************************************************
**************************************************************

We are very interested  in contacting anybody who has access to kindreds
with Bazex-Dupre-Christol Syndrome.  Thank you

Brandon Wainwright
B.Wainwright@MAILBOX.UQ.OZ.AU
**************************************************************

Dear Colleaques,
We have a project funded by Turkish Governmental Agency on the subject
of screening children for heterozygous familial hypercholesterolemia.
This project aims for at least screening 15000 children in Aegean region
of Turkey. At the moment we are searching for the current strategy and
methods for the measurement of LDL-cholesterol and total cholesterol in
blood speciemens. IS IT reliable and valid to use capillary blood? Which
commercial assay is it convenient? Which kind of questions should we ask
for families. Is there any guide for such a study?
We are also looking for collaboration for screening LDL-receptor gene
mutations in found patients in terms of standardization of mutation
screning strategy and the  estimation of possible exons etc.
 If there is anyone concerning on these issues, I would be very
gratefull.
THANK YOU VERY MUCH FOR ANY ASSISTANCE IN ADVANCE.
SELIM UZUNOGLU
EMAIL ADDRESS: SELIM@CBU.BAYAR.EDU.TR

 This a joint project prepared by Celal Bayar University in Manisa and 9
Eylul University Faculty of Medicine.
 Our Correspondence ADRESS: Dr Selim UZUNOGLU
                        CELAL BAYAR UNIVERSITY FACULTY OF MEDICINE, DEPT. OF
MED
ICAL BIOLOGY
AND GENETICS . MANISA- TURKEY
 FAX:+90-236-237 2442

CHIEF OF THE PROJECT.
PROF. DR. ORHAN TERZIOGLU,
DOKUZ EYLUL UNIVERSITY, FACULTY OF MEDICINE, DEPT. OF MEDICAL
BIOLOGY
AND GENETICS DEPT. INCIRALTI- IZMIR
FAX+90-232-2590541
**************************************************************

     We had a child with Werdnig-Hoffmann disease, who died. We want to
know if a test exists (and where it can be performed) which can give us a sure
answer on whether the disease was transmitted by the parents or not. Blood
samples from the child are available.

Apparent family location: Italy

PLEASE, REPLY TO HUMAN MOLECULAR GENETICS DIRECTLY


   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.